Equities

Trevi Therapeutics Inc

TRVI:NMQ

Trevi Therapeutics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)3.44
  • Today's Change-0.06 / -1.71%
  • Shares traded1.12m
  • 1 Year change+59.26%
  • Beta0.9644
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, Trevi Therapeutics Inc increased its cash reserves by 157.34%, or 19.81m. Cash Flow from Investing totalled 59.43m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 31.71m for operations while cash used for financing totalled 7.91m.
Cash flow per share-0.3869
Price/Cash flow per share--
Book value per share0.9116
Tangible book value per share0.9116
More ▼

Balance sheet in USDView more

Trevi Therapeutics Inc has little financial risk as the capital structure does not rely on leverage.
Current ratio10.68
Quick ratio--
Total debt/total equity0.0014
Total debt/total capital0.0014
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.